# HISTOPATHOLOGY SERVICES FOR STUDIES ON THERAPEUTICS TARGETING VIRUSES WITH PANDEMIC POTENTIAL

> **NIH NIH N02** · INTEGRATED LABORATORY SYSTEMS, LLC · 2022 · $315,417

## Abstract

To support histopathology services to facilitate product efficacy testing performed under the Preclinical Models of Infectious Diseases program with a focus on viruses with pandemic potential.

## Key facts

- **NIH application ID:** 10713073
- **Project number:** 75N93022P01143-0-0-1
- **Recipient organization:** INTEGRATED LABORATORY SYSTEMS, LLC
- **Principal Investigator:** MARY MULLEADY
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $315,417
- **Award type:** —
- **Project period:** 2022-09-06 → 2023-09-05

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10713073

## Citation

> US National Institutes of Health, RePORTER application 10713073, HISTOPATHOLOGY SERVICES FOR STUDIES ON THERAPEUTICS TARGETING VIRUSES WITH PANDEMIC POTENTIAL (75N93022P01143-0-0-1). Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/grant/nih/10713073. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*